Commentary: Protecting the rights of research participants-a cornerstone for advancing clinical research and infection control

Zheng Wu¹, Yingmei Feng^1*

¹Department of Science and Technology, Beijing Youan Hospital, Capital Medical University, Beijing, China.

*Correspondence: Yingmei Feng; Email: yingmeif13@ccmu.edu.cn.

The advancement of medicine is inseparable from clinical research, and the successful conduct of such research relies heavily on the support and dedication of research participants. These individuals not only make invaluable contributions to scientific and societal progress but also face potential risks and inconveniences. Therefore, safeguarding the rights of research participants—particularly their right to compensation—is an ethical obligation and a shared responsibility of all stakeholders involved in clinical research.

In life sciences and medical research involving human participants, their safety, health, and rights must always take precedence over scientific and societal benefits. Among these rights, the right to compensation is a critical component, reflecting respect for participants’ contributions and the risks they undertake. It also underscores the ethical foundation and social responsibility inherent in clinical research.

This article provides an in-depth exploration of the concept of compensation, its principles, key elements, and procedural frameworks. It further proposes a series of measures to ensure the protection of participants’ compensation rights. These measures encompass all major stakeholders, including sponsors, contract research organizations, research institutions, research management departments, principal investigators and their teams, as well as ethics (review) committees. Together, these measures offer comprehensive guidance for the effective implementation of compensation mechanisms.

Protecting the rights of research participants is not only an ethical imperative but also a cornerstone for fostering the healthy development of clinical research. This is particularly relevant in the field of infection control, where clinical research plays a pivotal role in exploring innovative diagnostic and therapeutic approaches and optimizing prevention strategies. The protection of participants’ rights is directly linked to the standardization, credibility, and sustainability of such research.

By publishing this article, we aim to provide a valuable reference for researchers and stakeholders in the field of infection control. We hope it will contribute to the ethical and standardized development of clinical research, ultimately advancing the prevention and control of infectious diseases.